focus -WSS

focus

author：knowledge 2025-09-27 10:04:13 - browse：93156

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Why scientists need input from humanists on sensitive research

WSS

Male and female sex labels in research insufficient, scientists say

Medicare coverage of Wegovy, once blocked, now looks possible

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Steward Health Care Massachusetts hospitals face fiscal disaster

CRISPR gene editing developments we’re watching in 2024

Steward Health Care Massachusetts hospitals face fiscal disaster

explore

focus

explore

Jerome Adams on the need for new antivirals for Covid

HCA sued by state AG for quality issues at Mission Health

Novavax promises a turnaround & Lilly roils the obesity market

Steward Health Care Massachusetts hospitals face fiscal disaster

Heart attack and stroke risk calculators need revising

Christmas in the PICU brings some surprising joy

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Activists slam private health insurers over coverage restrictions

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

explore

EPA limits use of carcinogenic gas for sterilizing medical devices

Three trends to watch in biotech in 2024

What STAT readers think about the FDA and patient advocacy

CRISPR gene editing developments we’re watching in 2024

HCA sued by state AG for quality issues at Mission Health

Why health records don't always know when patients are dead

hotspot

entertainment

hotspot

focus